TREATMENT-FREE RESPONSE USING BRAZILIAN IMATINIB COPIES AS FIRST LINE -RESULTS FROM TWO PROSPECTIVE CLINICAL TRIALS
- Resource Type
- Abstract
- Source
- In
Hematology, Transfusion and Cell Therapy October 2022 44 Supplement 2:S214-S215 - Subject
- Language
- ISSN
- 2531-1379